- Home
- FFC vs EMBC Comparison
FFC vs EMBC Comparison
Compare FFC & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FFC
- EMBC
- Stock Information
- Founded
- FFC 1983
- EMBC 1924
- Country
- FFC United States
- EMBC United States
- Employees
- FFC N/A
- EMBC N/A
- Industry
- FFC Trusts Except Educational Religious and Charitable
- EMBC Medical/Dental Instruments
- Sector
- FFC Finance
- EMBC Health Care
- Exchange
- FFC Nasdaq
- EMBC Nasdaq
- Market Cap
- FFC 741.9M
- EMBC 726.8M
- IPO Year
- FFC N/A
- EMBC N/A
- Fundamental
- Price
- FFC $16.24
- EMBC $9.64
- Analyst Decision
- FFC
- EMBC Hold
- Analyst Count
- FFC 0
- EMBC 3
- Target Price
- FFC N/A
- EMBC $17.00
- AVG Volume (30 Days)
- FFC 164.1K
- EMBC 691.8K
- Earning Date
- FFC 01-01-0001
- EMBC 08-08-2025
- Dividend Yield
- FFC 6.79%
- EMBC 6.25%
- EPS Growth
- FFC N/A
- EMBC N/A
- EPS
- FFC N/A
- EMBC 0.89
- Revenue
- FFC N/A
- EMBC $1,079,500,000.00
- Revenue This Year
- FFC N/A
- EMBC N/A
- Revenue Next Year
- FFC N/A
- EMBC N/A
- P/E Ratio
- FFC N/A
- EMBC $10.76
- Revenue Growth
- FFC N/A
- EMBC N/A
- 52 Week Low
- FFC $11.90
- EMBC $9.20
- 52 Week High
- FFC $14.96
- EMBC $21.48
- Technical
- Relative Strength Index (RSI)
- FFC 63.27
- EMBC 41.56
- Support Level
- FFC $15.84
- EMBC $9.54
- Resistance Level
- FFC $16.14
- EMBC $10.34
- Average True Range (ATR)
- FFC 0.12
- EMBC 0.46
- MACD
- FFC 0.00
- EMBC 0.04
- Stochastic Oscillator
- FFC 86.58
- EMBC 36.67
About FFC Flaherty & Crumrine Preferred and Income Securities Fund Incorporated
Flaherty & Crumrine Preferred and Income Securities Fund Incorporated is a diversified, closed-end management investment company. The fund's investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. It invests in a diversified portfolio of preferred securities.
About EMBC Embecta Corp.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.